Mitchell Mcleod Pugh & Williams Inc. Cuts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mitchell Mcleod Pugh & Williams Inc. decreased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 27.1% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 6,307 shares of the healthcare conglomerate’s stock after selling 2,346 shares during the quarter. UnitedHealth Group makes up 0.7% of Mitchell Mcleod Pugh & Williams Inc.’s portfolio, making the stock its 29th biggest position. Mitchell Mcleod Pugh & Williams Inc.’s holdings in UnitedHealth Group were worth $3,191,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Delta Financial Group Inc. lifted its stake in UnitedHealth Group by 1.0% during the 3rd quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock worth $965,000 after acquiring an additional 17 shares in the last quarter. First PREMIER Bank increased its holdings in UnitedHealth Group by 7.0% during the 3rd quarter. First PREMIER Bank now owns 274 shares of the healthcare conglomerate’s stock worth $160,000 after purchasing an additional 18 shares during the period. Genesee Capital Advisors LLC boosted its stake in shares of UnitedHealth Group by 1.9% in the 3rd quarter. Genesee Capital Advisors LLC now owns 990 shares of the healthcare conglomerate’s stock valued at $579,000 after buying an additional 18 shares during the period. Jmac Enterprises LLC lifted its stake in UnitedHealth Group by 2.2% in the third quarter. Jmac Enterprises LLC now owns 823 shares of the healthcare conglomerate’s stock worth $481,000 after acquiring an additional 18 shares during the last quarter. Finally, Matrix Private Capital Group LLC raised its holdings in shares of UnitedHealth Group by 3.6% in the 2nd quarter. Matrix Private Capital Group LLC now owns 542 shares of the healthcare conglomerate’s stock valued at $276,000 after purchasing an additional 19 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Performance

Shares of UNH opened at $510.03 on Tuesday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a market cap of $469.37 billion, a price-to-earnings ratio of 32.91, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. The company’s fifty day moving average is $549.37 and its 200-day moving average is $563.70. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter last year, the firm earned $5.83 EPS. Equities analysts expect that UnitedHealth Group Incorporated will post 29.77 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were paid a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.65%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on UNH. Morgan Stanley decreased their price objective on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a research note on Wednesday, October 16th. Hsbc Global Res upgraded shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Bank of America lowered their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Finally, Royal Bank of Canada cut their price objective on UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research report on Wednesday, October 16th. Two research analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $627.74.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.